Search

everythinglearnresearchcommunity

for

Search:↓

Some common medications can harm male fertility, but many effects can be reversed.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Acne significantly affects both physical health and mental well-being.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.